Rosiglitazone for type 2 diabetes mellitus

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1999年 / 41卷 / 1059期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：71 / +
页数：3
相关论文
共 50 条
  • [11] Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review
    Malinowski, JM
    Bolesta, S
    CLINICAL THERAPEUTICS, 2000, 22 (10) : 1151 - 1168
  • [12] Rosiglitazone in the management of older patients with type 2 diabetes mellitus
    Kreider, M
    Heise, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (07) : 538 - 541
  • [13] The use of a combination of metformin and rosiglitazone in type 2 diabetes mellitus
    Demidova, T. Y.
    DIABETES MELLITUS, 2007, 10 (03): : 27 - 31
  • [14] Rosiglitazone monotherapy for type 2 diabetes mellitus—too soon to ADOPT?
    Peter Gæde
    Oluf Pedersen
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 456 - 457
  • [15] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus Reply
    Zinman, Bernard
    LANCET, 2010, 376 (9750): : 1388 - 1388
  • [16] Rosiglitazone - A review of its use in the management of type 2 diabetes mellitus
    Wagstaff, AJ
    Goa, KL
    DRUGS, 2002, 62 (12) : 1805 - 1837
  • [17] The effect of rosiglitazone in overweight type 1 diabetes mellitus
    Strowig, SM
    Raskin, P
    DIABETES, 2004, 53 : A147 - A147
  • [18] Once-daily rosiglitazone is effective in the treatment of type 2 diabetes mellitus
    Nolan, JJ
    Jones, NP
    Patwardhan, R
    Deacon, LF
    DIABETES, 1999, 48 : A111 - A111
  • [19] The Effect of Rosiglitazone on the Expression of Thrombogenic Markers on Leukocytes in Type 2 Diabetes Mellitus
    Svobodova, H.
    Stulc, T.
    Kasalova, Z.
    Dolezalova, R.
    Marinov, I.
    Capek, P.
    Ceska, R.
    PHYSIOLOGICAL RESEARCH, 2009, 58 (05) : 701 - 707
  • [20] Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus
    Vrablik, Michal
    Dobiasova, Milada
    Stulc, Tomas
    Kasalova, Zdislava
    Dolezalova, Radka
    Prazny, Martin
    Fait, Tomas
    Ceska, Richard
    NEUROENDOCRINOLOGY LETTERS, 2008, 29 (01) : 146 - 150
12345